IRIS
STANZIONE, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 61.349
AS - Asia 8.111
EU - Europa 5.281
SA - Sud America 691
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 16
Totale 75.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 61.202
SG - Singapore 5.491
DE - Germania 1.290
CN - Cina 1.046
UA - Ucraina 864
RU - Federazione Russa 613
BR - Brasile 570
IT - Italia 547
HK - Hong Kong 530
IE - Irlanda 503
FR - Francia 401
VN - Vietnam 369
GB - Regno Unito 300
FI - Finlandia 206
PL - Polonia 199
KR - Corea 171
SE - Svezia 155
JP - Giappone 113
BD - Bangladesh 99
CA - Canada 79
IN - India 60
AR - Argentina 50
NL - Olanda 40
BE - Belgio 39
MX - Messico 32
AT - Austria 30
IQ - Iraq 30
TR - Turchia 30
ES - Italia 27
ID - Indonesia 27
ZA - Sudafrica 25
EC - Ecuador 22
EU - Europa 21
PH - Filippine 18
CO - Colombia 17
IL - Israele 15
AU - Australia 14
MA - Marocco 13
UZ - Uzbekistan 12
KG - Kirghizistan 11
PK - Pakistan 11
VE - Venezuela 11
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
CZ - Repubblica Ceca 9
MY - Malesia 9
RO - Romania 9
DK - Danimarca 8
KE - Kenya 8
LT - Lituania 8
TW - Taiwan 8
EG - Egitto 7
PY - Paraguay 7
CH - Svizzera 6
CR - Costa Rica 6
JM - Giamaica 6
NP - Nepal 6
DZ - Algeria 5
HN - Honduras 5
IR - Iran 5
AL - Albania 4
AZ - Azerbaigian 4
LB - Libano 4
RS - Serbia 4
TH - Thailandia 4
BB - Barbados 3
GE - Georgia 3
GR - Grecia 3
KZ - Kazakistan 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
DM - Dominica 2
ET - Etiopia 2
JO - Giordania 2
KH - Cambogia 2
LU - Lussemburgo 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
Totale 75.526
Salva come PNG Salva come JPEG
Città #
Woodbridge 19.076
Wilmington 15.569
Houston 14.626
Fairfield 1.821
Ann Arbor 1.462
Singapore 1.297
Ashburn 982
Jacksonville 791
Seattle 687
Cambridge 627
San Jose 613
Hong Kong 526
Dublin 496
Chandler 485
Beijing 427
Medford 375
Dearborn 275
Santa Clara 230
The Dalles 202
Lawrence 174
Kraków 170
New York 168
Los Angeles 136
Lauterbourg 126
Rome 116
Hanoi 106
Moscow 105
Council Bluffs 103
Ho Chi Minh City 101
San Diego 97
Zhengzhou 94
Buffalo 92
Tokyo 89
Dallas 80
Milan 77
Mülheim 75
Menlo Park 68
São Paulo 52
Falls Church 51
London 49
Chicago 37
Brussels 35
Munich 34
University Park 34
Verona 34
Helsinki 31
Redondo Beach 31
Nuremberg 30
Nürnberg 28
Phoenix 28
Mcallen 27
Boardman 25
Detroit 25
Norwalk 25
Brooklyn 24
Orem 24
Mountain View 23
Shanghai 23
Rio de Janeiro 22
Toronto 22
Warsaw 22
Chennai 20
Palo Alto 20
Kunming 19
Hefei 18
St Louis 18
Washington 18
Atlanta 17
Montreal 17
Johannesburg 16
Nanjing 16
North Bergen 16
San Francisco 16
Stockholm 16
Boston 15
Guangzhou 15
Haiphong 15
Manchester 15
Denver 14
Belo Horizonte 13
Da Nang 13
Redwood City 13
San Mateo 13
Guayaquil 12
Ankara 11
Dhaka 11
Hangzhou 11
Vienna 11
Curitiba 10
Jakarta 10
Tashkent 10
Amsterdam 9
Brasília 9
Columbus 9
Dong Ket 9
Guarulhos 9
Chengdu 8
Frankfurt am Main 8
Fuzhou 8
Hounslow 8
Totale 63.796
Salva come PNG Salva come JPEG
Nome #
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 617
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 612
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 603
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 600
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 594
Therapy for dyskinesias in Parkinson’s disease patients 592
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 588
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 571
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 567
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 557
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 551
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease 549
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 543
Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study 528
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. 523
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 523
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 516
123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study 515
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 507
Intra-arterial Thrombectomy versus Standard Intravenous Thrombolysis in Patients with Anterior Circulation Stroke Caused by Intracranial Arterial Occlusions: A Single-center Experience 507
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease 503
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 490
The role of dopamine receptors on lower urinary tract function in Parkinson's disease patients 489
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 489
Serial determinations of leukocyte aggregation in patients with ischemic stroke 487
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 485
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 484
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 484
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 477
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 473
Long-term Results of Drug-Eluting Balloon Angioplasty for Treatment of Refractory Recurrent Carotid In-Stent Restenosis 473
Spontaneous subarachnoid hemorrhage in an HIV patient 472
Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis 472
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 471
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 470
Effects of L-dopa on urodynamic findings in Parkinson's disease patients: Acute vs. chronic administration 469
Homeostatic changes of the endocannabinoid system in Parkinson's disease. 467
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 467
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 467
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 466
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 466
Serial determinations of leukocyte aggregation in patients with ischemic stroke 464
Collet-Sicard syndrome caused by a coiling of the internal carotid artery 462
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 462
Changes in cerebrovascular reactivity following low-frequency repetitive transcranial magnetic stimulation 458
Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience. 458
Effects of inhibitory rTMS on bladder function in Parkinson's disease patients 456
Perfusion-weighted dynamic susceptibility (DSC) MRI: basal ganglia hemodynamic changes after apomorphine in Parkinson's disease 456
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms 454
Cytotoxin-associated gene-A - Positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke 452
Evaluation of basal ganglia haemodynamic changes with perfusion-weighted magnetic resonance imaging in patients with Parkinson's disease 450
Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease 448
An investigation of hearing impairment in de-novo Parkinson's disease patients: A preliminary study 448
Safety of early carotid artery stenting after systemic thrombolysis: a single center experience 447
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 447
Boundary cerebral infarct in a case of essential thrombocythemia 446
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 446
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 445
Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease. 444
Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: An effective tool to investigate in vivo GABAergic cortical inhibition in humans 442
Ultrasound evaluation of early changes in arterial dissection 442
Stroke prevention: managing modifiable risk factors 442
Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy 442
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations 442
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease 440
Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients 440
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease 440
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 440
Proposal for a Vascular Computed Tomography-Based Grading System in Posterior Circulation Stroke: A Single-Center Experience 440
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: a case report 439
Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale 439
Non ulcer dyspepsia is associated with helicobacter pylori infection in patients with Parkinson's disease 438
Temporal administration of entacapone with slow release L-dopa: pharmacokinetic profile and clinical outcome 436
Saving the ischemic penumbra: Potential role for statins and phosphodiesterase inhibitors 435
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 435
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 435
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 434
An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson's disease 434
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 433
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 433
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 430
Urgent carotid endarterectomy: The role of serial ultrasound studies in early detection of plaque rupture 428
Encouraging and positive trend towards treatment of acute ischemic stroke performed by vascular interventional radiologist 428
Transcranial direct current stimulation of the affected hemisphere does not accelerate recovery of acute stroke patients 428
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study 427
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 426
Floating carotid thrombus treated by intravenous heparin and endarterectomy. 425
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 423
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 422
Efficacy of systemic thrombolysis within 4.5 h from stroke symptom onset: a single-centre clinical and diffusion-perfusion 3T MRI study. 421
Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease 421
H. pylori eradication improves L-dopa absorption in patients with Parkinson’s disease 420
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 419
Leukocyte aggregation: a possible link between infection and ischemic stroke 419
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine 419
Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials 419
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 418
Early DEtection of wEaring off in Parkinson disease: the DEEP study 418
Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease 417
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 417
Totale 46.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 155.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/20221.669 54 230 41 76 59 165 104 71 111 124 119 515
2022/20231.642 225 108 47 186 99 462 156 67 129 9 119 35
2023/2024522 67 21 43 7 43 104 20 59 19 8 8 123
2024/20256.603 110 881 388 209 99 206 270 141 345 262 2.092 1.600
2025/20265.944 459 253 783 466 535 176 683 825 683 603 262 216
Totale 75.969